Data for Retinal tissue knockout to study efflux of cholesterol (AGCA1/G1 double KO - TY and LysM cre) - part II (Study ST000682)

(Analysis AN001050)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4F5
CL 72:4; [M-2H](2-)@9.62 1.2446 0.9914 0.9336 0.7526 1.0842
CL 72:5; [M-2H](2-)@9.47 1.1469 0.8461 1.0632 0.8926 1.0682
CL 74:7; [M-2H](2-)@6.02 0.6878 1.1971 1.1036 1.1088 0.9501
FFA(16:0) 1.4398 0.7227 0.7718 0.7379 1.1723
FFA(18:0) 1.4203 0.7442 0.7597 0.7291 1.1811
FFA(18:1) 1.7322 0.8991 0.6342 0.5450 1.1171
FFA(18:2) 2.1259 0.7501 0.6104 0.4980 1.0359
FFA(20:0) 1.4914 0.7469 0.8115 0.7770 1.0953
FFA(20:1) 1.6726 0.8649 0.7117 0.5537 1.1381
FFA(20:2) 2.1438 0.8709 0.5046 0.5109 0.9834
FFA(20:4) Arachidonic acid 1.5119 0.7879 0.6196 0.6128 1.2356
FFA(22:0) 1.5148 0.7356 0.8473 0.8014 1.0619
FFA(22:1) 1.6349 0.7597 0.4331 0.6834 1.1818
FFA(22:2) 1.4178 0.9388 0.8547 0.8097 1.0008
FFA(22:3) 1.9167 0.8102 0.4469 0.5577 1.1065
FFA(24:0) 1.5141 0.4779 0.5309 1.1292 1.0243
FFA(24:2) 1.3972 0.9854 0.7852 0.9370 0.9096
lysoPE 18:0; [M-H]-@2.44 1.9032 0.7835 0.6294 0.6721 0.9953
N-(hexadecanoyl)-sphing-4-enine; [M-H]-@6.80 2.2012 0.9635 0.4781 0.4763 0.9409
N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.37 1.8533 0.8870 0.5291 0.5625 1.0757
PC 28:0; [M-Ac-H]-@5.19 1.2103 0.9173 0.7293 0.7282 1.2077
PC 30:0; [M-Ac-H]-@5.85 1.0101 0.9977 0.5712 0.9546 1.1374
PC 30:1; [M-Ac-H]-@5.41 1.0737 1.0283 0.7500 0.7534 1.1965
PC 31:0; [M-Ac-H]-@6.20 1.3440 0.7291 0.6652 0.7245 1.2538
PC 32:1; [M-Ac-H]-@6.00 1.2881 0.9398 0.7247 0.7724 1.1256
PC 33:0; [M-Ac-H]-@6.80 0.9451 1.2047 0.8500 0.9403 1.0074
PC 33:1; [M-Ac-H]-@6.36 1.1587 0.7723 0.8775 0.7471 1.2548
PC 34:1; [M-Ac-H]-@6.56 0.8691 1.0518 1.0157 0.9967 1.0381
PC 34:2; [M-Ac-H]-@6.17 1.0776 0.8967 1.0606 0.9181 1.0591
PC 35:1; [M-Ac-H]-@6.95 0.9894 0.9046 0.9813 1.0427 1.0257
PC 36:0; [M-Ac-H]-@7.66 0.9075 1.0306 0.8977 1.0138 1.0462
PC 36:1; [M-Ac-H]-@7.15 0.8797 0.9897 1.0278 1.0627 1.0113
PC 36:2; [M-Ac-H]-@6.72 0.9370 1.0360 1.0129 0.9689 1.0337
PC 36:3; [M-Ac-H]-@6.39 0.8606 1.0880 0.6187 0.8479 1.2351
PC 36:4; [M-Ac-H]-@6.15 1.0227 1.0165 0.7956 0.9040 1.1035
PC 36:6; [M-Ac-H]-@5.40 0.8209 0.6359 1.7622 1.0671 1.0308
PC 38:1; [M-Ac-H]-@7.74 0.8829 1.0300 0.9336 0.9809 1.0745
PC 38:2; [M-Ac-H]-@7.30 1.1883 0.7621 0.8637 1.0828 0.9968
PC 38:3; [M-Ac-H]-@7.04 1.6212 0.6850 0.9045 0.7790 1.0365
PC 38:6; [M-Ac-H]-@5.98 0.8720 0.8236 0.7947 1.2637 1.0057
PC 38:7; [M-Ac-H]-@5.59 1.2233 0.9337 0.7115 0.9399 1.0388
PC 39:6; [M-Ac-H]-@6.40 0.8044 1.0464 0.8936 1.1055 1.0221
PC 40:4; [M-Ac-H]-@7.23 0.6930 1.0359 0.7544 0.9700 1.2194
PC 40:5; [M-Ac-H]-@6.91 1.6635 0.6188 0.4697 0.6313 1.2679
PC 40:6; [M-Ac-H]-@6.65 0.7904 0.8997 0.7924 1.2544 1.0161
PC 42:10; [M-Ac-H]-@5.66 1.3484 0.7422 0.7281 0.8569 1.1300
PC 42:6; [M-Ac-H]-@7.31 0.7252 0.8577 1.0990 1.1820 1.0473
PC 42:8; [M-Ac-H]-@6.34 1.0658 0.6962 0.7808 1.0525 1.1344
PC 44:12; [M-Ac-H]-@5.51 0.9035 0.8183 0.6693 1.3652 0.9479
PE 32:0; [M-H]-@6.67 1.0425 1.1087 0.6839 0.9981 1.0048
PE 34:3; [M-H]-@5.99 0.9688 1.3540 0.6508 0.9119 0.9919
PE 35:0; [M-H]-@7.49 1.1366 0.9191 0.7384 0.8845 1.1241
PE 36:3; [M-H]-@6.46 1.3915 0.8228 0.8593 0.7722 1.0988
PE 36:5; [M-H]-@5.88 0.9887 0.8508 0.6766 1.2684 0.9598
PE 36:6; [M-H]-@5.37 0.9748 0.9406 0.7571 1.2578 0.9097
PE 37:4; [M-H]-@6.63 1.1264 1.3557 0.8374 0.9803 0.8144
PE 38:1; [M-H]-@7.83 0.9775 0.9752 0.9060 0.8815 1.1361
PE 38:2; [M-H]-@7.46 1.1371 0.7681 0.8482 0.8285 1.2140
PE 38:3; [M-H]-@7.19 1.5512 0.7085 0.6404 0.6647 1.2115
PE 40:4; [M-H]-@7.33 0.9827 1.0216 0.9307 0.9080 1.0841
PE 40:5; [M-H]-@7.04 1.6500 0.5793 0.5850 0.7083 1.2079
PE 40:9; [M-H]-@5.49 0.9762 0.7162 0.4516 1.2049 1.1372
PE 41:6; [M-H]-@7.15 0.8119 0.9503 0.5608 1.3058 0.9994
PE 42:7; [M-H]-@6.92 0.9615 0.7080 1.1483 1.2600 0.9332
PE 42:9; [M-H]-@6.06 0.7355 0.8752 0.9036 1.3542 0.9531
PE 44:10; [M-H]-@6.30 0.8920 1.1787 0.9030 1.1089 0.9072
PE 44:12; [M-H]-@5.63 0.8074 0.8046 0.6405 1.4456 0.9497
PG 32:0; [M-H]-@5.77 0.9440 0.9947 0.6700 0.8576 1.2200
PG 34:1; [M-H]-@5.82 1.0299 0.8959 0.9427 1.0192 1.0370
PG 34:2; [M-H]-@5.42 0.9394 1.3308 0.7162 0.9993 0.9364
PG 36:0; [M-H]-@6.89 1.0626 0.9924 0.5630 0.8471 1.1964
PG 36:2; [M-H]-@5.94 1.0022 0.8310 1.0277 1.1240 0.9835
PG 36:3; [M-H]-@5.62 1.6713 0.7621 0.8595 0.8802 0.9082
PG 36:4; [M-H]-@5.41 1.0209 0.9848 0.8706 1.1097 0.9472
PG 36:5; [M-H]-@5.03 1.2724 0.7315 0.7464 1.0653 1.0125
PG 38:4; [M-H]-@6.01 0.9646 0.9954 0.9236 0.9225 1.0972
PG 38:5; [M-H]-@5.54 1.3740 0.7383 0.7765 0.8001 1.1497
PG 38:6; [M-H]-@5.34 1.1061 0.8228 0.8401 1.1645 0.9521
PG 40:6; [M-H]-@5.95 1.1613 0.7283 0.8974 1.0991 1.0065
PG 40:7; [M-H]-@5.16 1.3784 0.9981 0.7011 0.9407 0.9309
PG 40:8; [M-H]-@4.64 0.8326 0.6956 1.2887 0.9792 1.1793
PG 42:10; [M-H]-@4.64 1.1143 0.8749 0.9394 0.9663 1.0458
PG 44:11; [M-H]-@4.73 1.5849 0.6864 0.8596 0.6615 1.1534
PG 44:12; [M-H]-@4.49 1.0546 0.8774 0.7719 0.8785 1.1822
PI 36:4; [M-H]-@5.22 1.1803 0.7423 0.9833 1.2068 0.8878
PI 38:4; [M-H]-@5.85 0.9247 1.0788 0.8541 1.0479 0.9988
plasmenyl-PE 32:0; [M-H]-@7.02 0.9862 1.0484 0.5635 0.8946 1.1709
plasmenyl-PE 34:0; [M-H]-@7.40 1.2310 0.7795 0.7404 0.8193 1.1952
plasmenyl-PE 34:1; [M-H]-@7.06 0.8635 1.0347 0.8609 0.8615 1.1896
plasmenyl-PE 34:2; [M-H]-@6.65 0.9911 1.1967 0.7210 1.0663 0.9261
plasmenyl-PE 36:2; [M-H]-@7.24 1.0555 1.3250 0.9079 0.8980 0.9093
plasmenyl-PE 38:2; [M-H]-@7.75 0.7547 1.8165 0.3110 0.9060 0.9572
plasmenyl-PE 38:3; [M-H]-@7.49 1.5269 0.7297 0.6432 0.6587 1.2168
plasmenyl-PE 40:4; [M-H]-@7.62 0.9367 0.9650 1.0061 0.9368 1.0951
PS 34:1; [M-H]-@5.99 1.2804 0.8548 0.7681 0.7314 1.1918
PS 34:2; [M-H]-@5.30 1.2733 0.9253 0.8236 1.0830 0.8826
PS 36:4; [M-H]-@5.31 0.8202 1.2326 0.8291 0.8298 1.1440
PS 38:4; [M-H]-@5.93 0.8226 1.0953 0.9154 1.0263 1.0425
PS 38:6; [M-H]-@5.21 0.9448 1.1439 0.6972 1.0157 1.0196
PS 40:4; [M-H]-@6.42 1.4061 0.7647 0.8037 0.6470 1.2285
PS 40:6; [M-H]-@5.88 0.9763 1.0038 0.7240 0.9550 1.1127
PS 40:7; [M-H]-@5.32 1.1836 0.7916 0.6226 0.7901 1.2642
PS 42:10; [M-H]-@4.78 1.0794 0.7117 0.9471 0.8918 1.1988
PS 42:11; [M-H]-@4.37 1.1474 0.8863 0.7575 1.1469 0.9336
PS 42:7; [M-H]-@5.97 1.1647 0.7439 0.8660 1.0090 1.0724
PS 42:9; [M-H]-@5.05 2.0785 0.8259 0.3245 0.8308 0.8435
PS 44:10; [M-H]-@5.32 1.0491 0.9664 0.6795 0.8607 1.1769
PS 44:11; [M-H]-@4.88 1.3838 0.5656 0.5365 0.9991 1.1419
PS 44:12; [M-H]-@4.67 0.8613 0.6399 0.7277 1.3953 1.0210
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1CRE:Cone Cre | SEX:f
F2CRE:Cone Cre | SEX:m
F3CRE:negative | SEX:f
F4CRE:negative | SEX:m
F5CRE:Rod Cre | SEX:f
  logo